CAM
NVO

Congress Asset Management’s Novo Nordisk NVO Stock Holding History

Congress Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,600
Closed -$356K – 363
2019
Q1 		$356K Sell
13,600
-294
-2% -$7.23K ﹤0.01% 330
2018
Q4 		$320K Hold
13,894
– – ﹤0.01% 340
2018
Q3 		$327K Buy
13,894
+294
+2% +$7.17K ﹤0.01% 347
2018
Q2 		$314K Hold
13,600
– – ﹤0.01% 346
2018
Q1 		$335K Hold
13,600
– – ﹤0.01% 357
2017
Q4 		$365K Hold
13,600
– – 0.01% 354
2017
Q3 		$327K Hold
13,600
– – 0.01% 369
2017
Q2 		$292K Hold
13,600
– – 0.01% 243
2017
Q1 		$233K Sell
13,600
-800
-6% -$13.9K ﹤0.01% 244
2016
Q4 		$258K Sell
14,400
-172,338
-92% -$3.12M 0.01% 245
2016
Q3 		$3.88M Buy
186,738
+2,248
+1% +$55.7K 0.09% 160
2016
Q2 		$4.96M Sell
184,490
-3,528
-2% -$96.8K 0.11% 131
2016
Q1 		$5.09M Buy
188,018
+282
+0.2% +$7.55K 0.12% 126
2015
Q4 		$5.45M Buy
187,736
+308
+0.2% +$8.53K 0.14% 119
2015
Q3 		$5.08M Buy
187,428
+6,456
+4% +$183K 0.13% 121
2015
Q2 		$4.96M Sell
180,972
-6,680
-4% -$188K 0.14% 132
2015
Q1 		$5.01M Buy
187,652
+90
+0% +$2.07K 0.12% 129
2014
Q4 		$3.97M Sell
187,562
-3,680
-2% -$82.2K 0.1% 138
2014
Q3 		$4.55M Buy
191,242
+166,942
+687% +$3.84M 0.12% 132
2014
Q2 		$561K Hold
24,300
– – 0.01% 198
2014
Q1 		$555K Sell
24,300
-4,200
-15% -$89.5K 0.01% 202
2013
Q4 		$527K Hold
28,500
– – 0.01% 194
2013
Q3 		$482K Hold
28,500
– – 0.01% 194
2013
Q2 		$442K Buy
+28,500
New +$474K 0.01% 193

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Congress Asset Management's NVO Position: Q2 2019 in Review

Congress Asset Management sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 13,600 shares — an estimated $356K sold.

Congress Asset Management first reported a position in NVO in Q2 2013 and held it in 24 quarters. The position peaked at $5.45M in Q4 2015. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Congress Asset Management reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
  • Congress Asset Management sold 13,600 Novo Nordisk shares in Q2 2019, an estimated $356K.
  • Congress Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 24 quarters.
  • Congress Asset Management's Novo Nordisk position peaked at $5.45M in Q4 2015.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Congress Asset Management's 13F filing for Q2 2019, filed 7 Aug 2019.